Table 1 Patient characteristics.
All patients: n (%) or median [range: min, max] | CytoSorb: n (%) or median [Range: min, max] | ADVOS: n (%) or median [Range: min, max] | Differences in both groups (p-value) | |
|---|---|---|---|---|
No. of patients | 39 (100) | 33 (100) | 6 (100) | |
Age, years | 55 [18, 80] | 55 [18, 76] | 46 [19, 80] | 0.84 |
Gender, male/female | 27 (69.2) / 12 (30.8) | 23 (69.7)/10 (30.3) | 4 (66.7) / 2 (33.3) | 0.92 |
BMI, kg/m2 | 27.7 [16.2, 55.1] | 27.8 [16.2, 55.1] | 26.0 [18.8, 35.2] | 0.56 |
ECMO therapy | 11 (28.2) | 10 (30.3) | 1 (16.7) | 0.61 |
7-days mortality | 12 (30.8) | 10 (30.3) | 2 (33.3) | 0.92 |
In-hospital mortality | 32 (82.1) | 28 (84.8) | 4 (66.7) | 0.51 |
SOFA score d0 | 20 [12, 23] | 20 [12, 23] | 21 [18, 23] | 0.48 |
SAPS II d0 | 80 [47, 111] | 80 [47, 109] | 72 [50,111] | 0.53 |
MELD score d0 | 35.0 [25.4, 52.9] | 33.6 [25.4, 52.9] | 38.5 [30.5, 44.8] | 0.10 |
MELD score d1 | 34.4 [25.8, 52.3] | 33.8 [25.8, 52.3] | 38.5 [30.1, 45.8] | 0.23 |
Total bilirubin (mg/dl) d-1 | 16.8 [4.2, 40.2] | 14.2 [4.2, 40.2] | 18.5 [11.7, 26.9] | 0.35 |
Total bilirubin (mg/dl) d0 | 17.3 [10.2, 41.1] | 16.9 [10.2, 41.1] | 17.7 [10.7, 28.0] | 0.89 |
Total bilirubin (mg/dl) d1 | 13.3 [5.2, 25.6] | 13.2 [5.2, 25.6] | 15.9 [6.8, 21.9] | 0.81 |
